Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 17, 2020, titled "Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets".